Illumina Inc

Type: Company
Name: Illumina Inc
Nationality: United States
Web Address: http://www.illumina.com/
First reported 3 hours ago - Updated 3 hours ago - 1 reports

Reports Summarize Biotechnology Study Results from J. Canales and Co-Researchers

(NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- A new study on Biotechnology is now available. According to news originating from Cestas, France, by NewsRx correspondents, research stated, "Maritime pine (Pinus pinasterAit.) ... [Published NewsRX - 3 hours ago]
First reported 19 hours ago - Updated 19 hours ago - 1 reports

What's next: Earnings and business reports due April 18-22 (Video)

Notable expected earningsFRIDAY: [Good Friday holiday]MONDAY: Halliburton, Hasbro, Kimberly-Clark, Netflix, Rent-A-Center, Rogers Communication, SunTrust Banks.TUESDAY: Amgen, AT&T, Bank of New York Mellon, Comcast, Cree Inc., Discover Financial Services, ... [Published Business First of Buffalo - 19 hours ago]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Edico Genome Aims at Data Processing Bottleneck in Genome Sequencing

With the arrival of next-generation gene sequencing machines like the Illumina (NASDAQ: ILMN) HiSeq X Ten, medicine has been moving to develop new ways of using genomic data to treat patients. Last month, for example, as an initial goal for his latest ... [Published Xconomy - Apr 17 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Researchers from Karlsruhe Institute of Technology Report on Findings in Bioinformatics

By a News Reporter-Staff News Editor at Information Technology Newsweekly -- Current study results on Bioinformatics have been published. According to news originating from Karlsruhe, Germany , by VerticalNews correspondents, research stated, "The Illumina ... [Published 4 Traders - Apr 17 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Methods and compositions for in vitro and in vivo chondrogenesis

Aspects of the present invention include methods and compositions related to the production, identification and use of embryonic progenitor cell lines that are capable of undergoing chondrogenesis. A number of exemplary chondrogenic cell lines derived ... [Published PharmCast - Apr 17 2014]
First reported Apr 16 2014 - Updated Apr 17 2014 - 3 reports

Insider Selling: Daniel Bradbury Sells 2,100 Shares of Illumina Stock (ILMN)

Illumina (NASDAQ:ILMN) Director Daniel Bradbury sold 2,100 shares of the company’s stock on the open market in a transaction dated Tuesday, April 15th. The stock was sold at an average price of $131.29, for a total transaction of $275,709.00. Following ... [Published American Banking News - Forex - Apr 17 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

The 4 Stocks That Floated the Market

: Markets opened higher on Wednesday with shares getting a boost in midmorning from the report on crude oil and gasoline stockpiles. The midafternoon release of the Fed’s Beige Book and a speech by Fed Chairwoman Janet Yellen kept the ball rolling right ... [Published 24/7 Wall St - Apr 16 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

MIT “Accidently” Reveals An Enormous American Secret

Submitted by Wall St. Daily as part of our contributors program MIT Technology Review just published its list of the world’s “50 Smartest Companies.”The list is strictly a reflection of the companies having the biggest market impact through the sheer ... [Published Trefis - Apr 16 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

Illumina : Bolsters Product Portfolio to Support Oncology Clinical Research and Discovery

Illumina, Inc. announced new products that can be applied directly to the discovery and translation of genomic variation in blood and tissue associated with cancer.According to a release, the expanded portfolio leverages the company's next-generation ... [Published 4 Traders - Apr 16 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

Better Buy: Illumina, Inc. Vs. Intuitive Surgical, Inc.

Health care investors have never been shy about rewarding innovation. Biotech companies continually sport nosebleed valuation based on assumptions that new, game-changing therapies will improve patient outcomes.But biotech isn't the only health care industry ... [Published Motley Fool Discussion Boards - Apr 15 2014]
First reported Apr 14 2014 - Updated Apr 14 2014 - 1 reports

Illumina Price Target Cut to $160.00 by Analysts at Goldman Sachs (ILMN)

Tweet[embedded content]Illumina (NASDAQ:ILMN) had its price target reduced by Goldman Sachs from $162.00 to $160.00 in a research note issued to investors on Friday, AnalystRatingsNetwork reports. The firm currently has a neutral rating on the stock.Goldman ... [Published Zolmax News - Apr 14 2014]
First reported Apr 12 2014 - Updated Apr 12 2014 - 2 reports

Goldman Sachs Lowers Illumina Price Target to $160.00 (ILMN)

Investment analysts at Goldman Sachs cut their target price on shares of Illumina (NASDAQ:ILMN) Illumina (NASDAQ:ILMN) traded down 0.37% during mid-day trading on Friday, hitting $135.24. 3,214,477 shares of the company’s stock traded hands. Illumina ... [Published American Banking News - Forex - Apr 12 2014]

Quotes

Our news journalists obtained a quote from the research, "De novo assembly of the... We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3."
According to new marketmarket research report, "Nucleic Acid Isolation and Purification Market by Technology (Column based, Reagent based, Magnetic bead based), Consumables & Instruments, Application (Plasmid DNA isolation, MIRNA isolation, Total RNA isolation), & End users - Global Forecasts to 2018" published by MarketsandMarkets, the global nucleic acid isolation and purification market over the forecast period of 2013 to 2018
"It gets to a point where that stops happening and the rest of the market - outside of these crazy names - is not that overvalued."
...to map the same RNA-seq dataset to the same transcriptome reference sequence that was used in [25], and the Bowtie result was taken from Su et al. "s report [25]. To be comparable to the microarray used in Su et al." s study, only the reads mapped to the coding genes were considered...

More Content

All (570) | News (432) | Reports (0) | Blogs (127) | Audio/Video (0) | Fact Sheets (0) | Press Releases (10)
sort by: Date | Relevance
Reports Summarize Biotechnology Study Results f... [Published NewsRX - 3 hours ago]
MarketsandMarkets: Nucleic Acid Isolation and P... [Published Individual.com - 6 hours ago]
Wall St Week Ahead-Spring fever brings hope for... [Published Reuters - 11 hours ago]
FANSe2: A Robust and Cost-Efficient Alignment T... [Published PLoS medicine - 13 hours ago]
Genetic Control of Differential Acetylation in ... [Published PLoS medicine - 13 hours ago]
What's next: Earnings and business reports due ... [Published Business First of Buffalo - 19 hours ago]
Biotech ETF Experiences Big Outflow [Published Self Directed Investor - 19 hours ago]
Potential Illumina (ILMN) Trade Has 8.81% Downs... [Published MarketIntelligenceCenter.com - 23 hours ago]
Deciphering gamma-decalactone biosynthesis in s... [Published BMC - Apr 17 2014]
Edico Genome Aims at Data Processing Bottleneck... [Published BioPortfolio - Apr 17 2014]
Researchers from Karlsruhe Institute of Technol... [Published 4 Traders - Apr 17 2014]
Edico Genome Aims at Data Processing Bottleneck... [Published Xconomy - Apr 17 2014]
Methods and compositions for in vitro and in vi... [Published PharmCast - Apr 17 2014]
Insider Selling: Daniel Bradbury Sells 2,100 Sh... [Published American Banking News - Forex - Apr 17 2014]
Insider Selling: Illumina SVP Sells 2,000 Share... [Published American Banking News - Forex - Apr 17 2014]
Researchers Submit Patent Application, "Multipl... [Published HispanicBusiness.com - Apr 17 2014]
Dickkopf-Related Protein 1 Inhibits the WNT Sig... [Published PLoS medicine - Apr 16 2014]
Quantitative Trait Loci (QTL) Study Identifies ... [Published PLoS medicine - Apr 16 2014]
A High Throughput Single Nucleotide Polymorphis... [Published PLoS medicine - Apr 16 2014]
The 4 Stocks That Floated the Market [Published 24/7 Wall St - Apr 16 2014]
Rare copy number variations containing genes in... [Published 7thSpace - Apr 16 2014]
Molecular Diagnostics Markets [Published Sacramento Bee - Apr 16 2014]
Concise Analysis of the International Molecular... [Published Yahoo! Finance - Apr 16 2014]
Illumina (ILMN) Showing Support Near $123.28 [Published MarketIntelligenceCenter.com - Apr 16 2014]
MIT “Accidently” Reveals An Enormous American S... [Published Trefis - Apr 16 2014]
Illumina : Bolsters Product Portfolio to Suppor... [Published 4 Traders - Apr 16 2014]
Expression of a Truncated ATHB17 Protein in Mai... [Published PLoS medicine - Apr 15 2014]
Sequenom scores a blow against Illumina in pren... [Published Fierce BioMarkers - Apr 15 2014]
Gene panels may provide ‘middle ground’ for gen... [Published Orthopedics Today - Apr 15 2014]
Better Buy: Illumina, Inc. Vs. Intuitive Surgic... [Published Motley Fool Discussion Boards - Apr 15 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Potential Illumina (ILMN) Trade Has 8.81% Downs... [Published MarketIntelligenceCenter.com - 23 hours ago]
The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artifical Intelligence Center found a trading opportunity with Illumina Inc (ILMN) that should provide a 8.68% return in just 65 days. Buy one Jun. '14 call at the ...
Illumina (ILMN) Showing Support Near $123.28 [Published MarketIntelligenceCenter.com - Apr 16 2014]
Illumina Inc (ILMN) is a good candidate for a covered call at the $130.00 level. The Jun. '14 call at that price should fetch a credit of about $11.90, which means the entire position has a net debit of about $119.15. This trade has 6.71% downside protection. ...
Illumina (ILMN) Trading Near $125.97 Support Level [Published MarketIntelligenceCenter.com - Apr 15 2014]
A covered call identified by MarketIntelligececenter.com's patented algorithms on Illumina Inc (ILMN) could yield about 8.84% (48.17% annualized, for comparison purposes only) in 67 days. Pair a long position in the stock with the Jun. '14 $130.00 call ...
Illumina (ILMN) Showing Resistance Near $147.01 [Published MarketIntelligenceCenter.com - Apr 14 2014]
Illumina Inc (ILMN) was identified by MarketIntelligenceCenter.com’s patented algorithms today after trading between $129.11 and $141.00 on Friday before closing at $135.24. A diagonal spread using a long position in the Jan. '15 $82.50 call and a short ...
Cliff Reid on Regulation and Genomic Medicine [Published mendelspod.com - Apr 10 2014]
Guest: Cliff Reid , CEO, Complete Genomics Bio and Contact Info Listen (3:55) What do you make of recent crackdown on genetic testing in China? Listen (5:19) Self pay model better for health care Listen (2:08) What is the ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Critical Alerts For Dish Network, Plug Power, I... [Published Financial Services - Apr 08 2014]
Critical Alerts For Exxon, Sears, Mastercard, A... [Published Financial Services - Mar 13 2014]
Critical Alerts For 3D Systems, JA Solar, Apoll... [Published Financial Services - Feb 13 2014]
Critical Alerts For Tesla, Canadian Solar, ResM... [Published Financial Services - Jan 15 2014]
New Appointments, and Share Price Movements - R... [Published Financial Services - Dec 24 2013]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.